Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 68

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 1
Chunk 68
---

February 5, 2025, the Company announced the pricing of a reasonable best efforts public offering (the “Offering”), with participation
from a member of the Company’s board of directors and a single institutional investor, for the purchase and sale of (i) 15,000
shares of common stock, (ii) 112,500 February 2025 Pre-funded Warrants; and (iii) common warrants to purchase up to 127,551 shares of
common stock (the “February 2025 Common Warrants”), at a combined public offering price of $39.20 per share and Warrant (See
Note 8).

The
following table summarizes the pre-funded warrants and February 2025 Common Warrants sold to our related party:

    Purchasers 
    Pre-Funded
    Warrants Purchased  
    Total
    Purchase Price  
    February
    2025 Common Warrants Issued 
  
    Atwood-Edminster
    Trust dtd 4-2-2000 and GVN, LLC (2) 
     25,510  
    $999,992  
     25,510 

  (1) Daniel Corey served as the Chief Technology Officer and a member of the board of directors of the Company from February 2024 to September 2024, and previously served as Chief Executive Officer, Chief Scientific Officer, and a member of the board of directors of Legacy CERo until the closing of the Business Combination in February 2024. 

(2)Brian G. Atwood served as Chairman and Chief Executive Officer of the Company from February 2024 to September 2024, and previously served as Chairman of PBAX until the closing of the Business Combination in February 2024. Mr. Atwood is currently a member of the board of directors of the Company and serves as a trustee of Atwood-Edminster Trust dtd 4-2-2000. GVN, LLC, is a limited liability company of which the sole member is the Atwood-Edminster Trust dtd 4-2-2000, and of which Brian G. Atwood and Lynne H. Edminster are the managers.

(3)Chris Ehrlich has served as the Chairman and Chief Executive Officer of the Company since December 2024, and previously served as (i) interim Chairman and Chief Executive Officer of the Company from October 2024 to November 2024, (ii) Vice